# A Study to Evaluate the Effect of Lansoprazole on Hospitalized Neonates With Gastroesophageal Reflux Disease

> **NCT00174928** · PHASE1 · COMPLETED · sponsor: **Takeda** · enrollment: 24 (actual)

## Conditions studied

- Gastroesophageal Reflux Disease

## Interventions

- **DRUG:** Lansoprazole
- **DRUG:** Lansoprazole

## Key facts

- **NCT ID:** NCT00174928
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-05
- **Primary completion:** 2005-08
- **Final completion:** 2005-08
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2010-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00174928

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00174928, "A Study to Evaluate the Effect of Lansoprazole on Hospitalized Neonates With Gastroesophageal Reflux Disease". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT00174928. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*